Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.
about
Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4Vaccines: the Fourth CenturyTwenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative.New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After EradicationA new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys.Invasion thresholds and the evolution of nonequilibrium virulenceCold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine.Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game.Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern NigeriaNew generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis.The final stages of the global eradication of poliomyelitis.Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons.Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains.Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.Innovative IPV from attenuated Sabin poliovirus or newly designed alternative seed strains.Polio vaccination: past, present and future.Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame.SAT2 Foot-and-Mouth Disease Virus Structurally Modified for Increased ThermostabilityAlternative administration routes and delivery technologies for polio vaccines.The potential benefits of a new poliovirus vaccine for long-term poliovirus risk management.Poliovirus vaccination during the endgame: insights from integrated modeling.Generation of Infectious Poliovirus with Altered Genetic Information from Cloned cDNA.Development of an optimized RNA-based murine norovirus reverse genetics systemThe risk of type 2 oral polio vaccine use in post-cessation outbreak response.Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.
P2860
Q27485404-4F66EF4D-A832-413B-A3B1-EA6A90C2F9A3Q27490454-1D7CB4FD-6ECC-4585-AFBD-61937CE846CFQ35757398-7E34B887-1C15-4AAE-AE2E-D94E6C374395Q35882532-7B970BE8-D647-4F7D-952F-20E94E92294DQ35947906-8606EBFE-CEE1-4ACC-81CC-083CFF73567FQ35948053-CCB0FE55-65FA-4F3F-B97D-F3B338236A4BQ35960723-00BD00F5-80C4-462D-A750-64AA896AD0EAQ35975620-65AD5A2D-3E09-4557-942E-A9C9752E928FQ36523940-45CBE740-0AAB-43BC-AD7C-88FDEC1DC0A8Q36760045-8951F5F2-D9F8-4E06-9F05-5277566BCCFDQ37001439-DD1F443D-BD83-4EB4-8A14-9F3EBA8D272EQ37037388-C16D3BE1-5702-48BB-9754-0D00F3C47995Q37355985-91BEE4C5-40B3-4C33-BD2C-007316C6F2B9Q37878482-9F4E545D-80EC-4254-89E3-99C93B6C8C4EQ38028997-63433B6A-48D4-43AF-91F2-CCC3BAAAE2BFQ38162948-6E80DBD6-440B-4831-94D6-2798A3E97AECQ38396773-E7CF0F8F-A59E-4C98-95A4-8370CCBE57EAQ38544598-A1FDDEF7-48DE-46C3-8C3E-8AFB7A69932AQ38744534-86DFD3AF-EDEC-4B8C-8E30-B46633FFB78FQ38748979-125559A8-EF1D-4893-9309-F737AB29FDA4Q38796753-595AF303-9C24-4962-86DC-04414B0F96B5Q39258694-C107227D-8BF9-40C5-A1DC-BE63A2A4B141Q40752740-44726AD0-B2D0-4173-A6A0-1D4C33C4BF58Q41685641-AECC9A8D-D17F-4FD2-A6A8-BCB7F18FC9F1Q41925239-9AFCE38C-5167-4FEA-BCF0-B3F0B71EE13AQ55114845-5A9ADCDC-08F8-44FF-973A-BCC7397EAEBA
P2860
Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Rational design of genetically ...... to poliomyelitis eradication.
@en
type
label
Rational design of genetically ...... to poliomyelitis eradication.
@en
prefLabel
Rational design of genetically ...... to poliomyelitis eradication.
@en
P2093
P2860
P921
P356
P1433
P1476
Rational design of genetically ...... to poliomyelitis eradication.
@en
P2093
Andrew J Macadam
David M Stone
Geraldine Ferguson
Ghazi Auda
Janet Meredith
Jeffrey W Almond
Philip D Minor
Sarah Knowlson
P2860
P304
P356
10.1128/JVI.00370-06
P407
P577
2006-09-01T00:00:00Z